SCHEMBL22845080

SCHEMBL22845080

CC[C@]12CCC3C(CCC4=CC(=O)CC[C@@H]43)C1CCC2=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.69
▸ PGR P06401 5/20 0.55
▸ CYP3A4 P08684 4/20 0.55
▸ LMNA P02545 4/20 0.55
▸ AR P10275 3/20 0.55
▸ SLC6A4 P31645 3/20 0.55
▸ SHBG P04278 3/20 0.55
▸ ABCB11 O95342 3/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ NR3C1 P04150 2/20 0.55
▸ CYP2C19 P33261 2/20 0.55
▸ ESR1 P03372 2/20 0.55
▸ POLB P06746 1/20 0.55
▸ SERPINA6 P08185 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ SLC22A1 O15245 1/20 0.55
▸ THRB P10828 1/20 0.55
▸ NR3C2 P08235 1/20 0.54
▸ TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16661457 1.00 CYP19A1 (0.69) CYP19A1PGRCYP3A4LMNAAR
SCHEMBL20851687 1.00 CYP19A1 (0.69) CYP19A1PGRCYP3A4LMNAAR
SCHEMBL1422567 1.00 CYP19A1 (0.69) CYP19A1PGRCYP3A4LMNAAR
SCHEMBL3182567 1.00 CYP19A1 (0.69) CYP19A1PGRCYP3A4LMNAAR
SCHEMBL11629995 1.00 CYP19A1 (0.69) CYP19A1PGRCYP3A4LMNAAR
SCHEMBL11629999 1.00 CYP19A1 (0.69) CYP19A1PGRCYP3A4LMNAAR
SCHEMBL11755439 0.90 CYP19A1 (0.66) CYP19A1PGRCYP3A4LMNAAR
SCHEMBL6832274 0.88 CYP19A1 (0.65) CYP19A1PGRCYP3A4LMNAAR
SCHEMBL4107677 0.86 CYP19A1 (0.57) CYP19A1PGRCYP3A4LMNAAR
SCHEMBL16937732 0.85 CYP19A1 (0.62) CYP19A1PGRCYP3A4LMNAAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020264512-A1 COMPOUNDS FOR TREATING CNS DISORDERS SAGE THERAPEUTICS, INC. (US) 2020-12-30 — — WO disclosed
Send feedback